In the BioHarmony Drug Report Database

"Preview" Icon

Nalidixic acid

Neggram (nalidixic acid) is a small molecule pharmaceutical. Nalidixic acid was first approved as Neggram on 1982-01-01. It is used to treat escherichia coli infections, klebsiella infections, proteus infections, salmonella infections, and urinary tract infections in the USA.

 

Trade Name

 

Neggram
 

Common Name

 

nalidixic acid
 

ChEMBL ID

 

CHEMBL5
 

Indication

 

escherichia coli infections, klebsiella infections, proteus infections, salmonella infections, urinary tract infections
 

Drug Class

 

Narcotic agonists/antagonists (normorphine type)

Image (chem structure or protein)

Nalidixic acid structure rendering